Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Baxter
Cerilliant
Julphar
Johnson and Johnson
Deloitte
UBS
McKinsey
Dow
Mallinckrodt

Generated: August 18, 2017

DrugPatentWatch Database Preview

Naloxegol oxalate - Generic Drug Details

« Back to Dashboard

What are the generic sources for naloxegol oxalate and what is the scope of naloxegol oxalate freedom to operate?

Naloxegol oxalate
is the generic ingredient in one branded drug marketed by Astrazeneca Pharms and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Naloxegol oxalate has eighty-eight patent family members in thirty-seven countries.

Three suppliers are listed for this compound.

Summary for Generic Name: naloxegol oxalate

Tradenames:1
Patents:6
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Clinical Trials: see list68
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:naloxegol oxalate at DailyMed

Pharmacology for Ingredient: naloxegol oxalate

Drug ClassOpioid Antagonist
Mechanism of ActionOpioid Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Pharms
MOVANTIK
naloxegol oxalate
TABLET;ORAL204760-001Sep 16, 2014RXYesNo► Subscribe► SubscribeYY ► Subscribe
Astrazeneca Pharms
MOVANTIK
naloxegol oxalate
TABLET;ORAL204760-002Sep 16, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
MOVANTIK
naloxegol oxalate
TABLET;ORAL204760-001Sep 16, 2014RXYesNo► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
MOVANTIK
naloxegol oxalate
TABLET;ORAL204760-001Sep 16, 2014RXYesNo► Subscribe► Subscribe ► Subscribe
Astrazeneca Pharms
MOVANTIK
naloxegol oxalate
TABLET;ORAL204760-002Sep 16, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: naloxegol oxalate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,015,197,470► Subscribe
9,388,104Chemically modified small molecules► Subscribe
8,034,825Chemically modified small molecules► Subscribe
9,149,539Crystalline naloxol-PEG conjugate► Subscribe
8,349,307Polymer conjugates of opioid antagonists► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: naloxegol oxalate

Country Document Number Estimated Expiration
Israel176317► Subscribe
Australia2014280956► Subscribe
Guatemala201300084► Subscribe
Japan2007514761► Subscribe
European Patent Office2621496► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: NALOXEGOL OXALATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00737Netherlands► SubscribePRODUCT NAME: NALOXEGOL ALSMEDE DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/14/962 20141208
4 5008-2015Slovakia► SubscribePRODUCT NAME: OXALAT NALOXEGOLU; REGISTRATION NO/DATE: EU/1/14/962 20141210
2015019Lithuania► SubscribePRODUCT NAME: NALOXEGOLUM; REGISTRATION NO/DATE: EU/1/14/962 20141208
90027-7Sweden► SubscribePRODUCT NAME: NALOXEGOL; REG. NO/DATE: EU/1/14/962 20141210
2015 00028Denmark► SubscribePRODUCT NAME: OXYLATSALT AF NALOXEGOL; REG. NO/DATE: EU/1/14/962 20141210
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Dow
US Army
Julphar
Baxter
Medtronic
Federal Trade Commission
Covington
Deloitte
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot